U.S. Department of Veterans Affairs-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:U.S. Department of Veterans Affairs - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013507
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
U.S. Department of Veterans Affairs (DVA) is a healthcare organization that provides benefit management and veteran services. The organization provides general benefits information, disability compensation, pension, GI bill, vocational rehabilitation and employment, vet success, educational counselling services, and others. It offers services such as survivor benefits, home loans, life insurance, traumatic injury insurance, healthcare information, crisis prevention, cemetery services, burial allowance, burial flags, presidential memorial certificates and mental healthcare, among others. DVA operates hospitals and clinics, vet centers, regional benefits offices and regional loan centers, among others. The organization operates in Atlanta, Denver, Indianapolis, Oakland, Philadelphia, and others. DVA is headquartered in Washington D.C., the US.

U.S. Department of Veterans Affairs – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
U.S. Department of Veterans Affairs, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
U.S. Department of Veterans Affairs, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
U.S. Department of Veterans Affairs, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
U.S. Department of Veterans Affairs, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
U.S. Department of Veterans Affairs, Medical Devices Deals, 2011 to YTD 2017 9
U.S. Department of Veterans Affairs, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
U.S. Department of Veterans Affairs, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
MediciNova Enters into Agreement with US Department of Veterans and Oregon Health & Science 11
Palo Alto Health Sciences Enters into Agreement with VA Palo Alto Health Care System 12
Cogito Enters into Contract Agreement with US Department of Veterans Affairs 13
Sequenom enters into an Agreement with University of California 14
VA Palo Alto Health Care Enters Into Co-Dvelopment Agreement With Fujitsu Labs 15
Licensing Agreements 16
Rubicon Biotech Enters into Licensing Agreement with US Department of Veterans Affairs 16
U.S. Department of Veterans Affairs – Key Employees 17
U.S. Department of Veterans Affairs – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Affiliate 28
Recent Developments 29
Government and Public Interest 29
Jul 06, 2016: NIH awards $55 million to build million-person precision medicine study 29
Product News 31
Jun 01, 2016: Scientists Discover and Test New Class of Pain Relievers 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
U.S. Department of Veterans Affairs, Pharmaceuticals & Healthcare, Key Facts 2
U.S. Department of Veterans Affairs, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
U.S. Department of Veterans Affairs, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
U.S. Department of Veterans Affairs, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
U.S. Department of Veterans Affairs, Deals By Therapy Area, 2011 to YTD 2017 8
U.S. Department of Veterans Affairs, Medical Devices Deals, 2011 to YTD 2017 9
U.S. Department of Veterans Affairs, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
MediciNova Enters into Agreement with US Department of Veterans and Oregon Health & Science 11
Palo Alto Health Sciences Enters into Agreement with VA Palo Alto Health Care System 12
Cogito Enters into Contract Agreement with US Department of Veterans Affairs 13
Sequenom enters into an Agreement with University of California 14
VA Palo Alto Health Care Enters Into Co-Dvelopment Agreement With Fujitsu Labs 15
Rubicon Biotech Enters into Licensing Agreement with US Department of Veterans Affairs 16
U.S. Department of Veterans Affairs, Key Employees 17
U.S. Department of Veterans Affairs, Subsidiaries 18
U.S. Department of Veterans Affairs, Affiliate 28

★海外企業調査レポート[U.S. Department of Veterans Affairs-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • DiaCarta Inc:医療機器:M&Aディール及び事業提携情報
    Summary DiaCarta Inc (DiaCarta) is a developer of molecular diagnostics products for cancer and infectious diseases. The company offers genomic testing for biomarkers and also provides clinical sample testing services in their CLIA-certified lab. It offers products such as gene mutation detection ki …
  • Air Water Inc (4088):企業の財務・戦略的SWOT分析
    Air Water Inc (4088) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Energiekontor AG (EKT):企業の財務・戦略的SWOT分析
    Summary Energiekontor AG (Energiekontor) is a renewable energy company that develops and operates offshore wind farms. It offers services which include construction, designing, engineering, planning, operation, and management of wind farms. The company also provides project financing, project manage …
  • Arcelik A.S. (ARCLK):企業の財務・戦略的SWOT分析
    Arcelik A.S. (ARCLK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Newell Brands Inc (NWL):企業の財務・戦略的SWOT分析
    Newell Brands Inc (NWL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • FirstCaribbean International Bank Limited:企業の戦略的SWOT分析
    FirstCaribbean International Bank Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • RUAG Holding AG:企業の戦略・SWOT・財務情報
    RUAG Holding AG - Strategy, SWOT and Corporate Finance Report Summary RUAG Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Transat A.T. Inc:戦略・SWOT・企業財務分析
    Transat A.T. Inc - Strategy, SWOT and Corporate Finance Report Summary Transat A.T. Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Gujarat State Electricity Corporation Ltd:企業の戦略的SWOT分析
    Gujarat State Electricity Corporation Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Pacific Edge Ltd (PEB)-医療機器分野:企業M&A・提携分析
    Summary Pacific Edge Ltd (PEB) is a diagnostics company that discovers, develops and commercializes diagnostic tests for the early detection and monitoring of cancer. The company provides lead product such as Cxbladder, a non-invasive laboratory test for the detection of bladder cancer. It is develo …
  • Wincanton Plc (WIN):企業の財務・戦略的SWOT分析
    Wincanton Plc (WIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Misonix Inc (MSON)-医療機器分野:企業M&A・提携分析
    Summary Misonix Inc (Misonix) is a medical technology company that provides ultrasonic surgical devices for neurosurgical, spinal, advanced wound care and general surgery procedures. The company’s major products include BoneScalpel cutting system; SonaStar surgical aspirator; SonicOne wound cleansin …
  • Host Hotels & Resorts Inc (HST):企業の財務・戦略的SWOT分析
    Host Hotels & Resorts Inc (HST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • The Charles Schwab Corporation:企業のM&A・事業提携・投資動向
    The Charles Schwab Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Charles Schwab Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • PTT Exploration and Production Public Co Ltd (PTTEP):企業の財務・戦略的SWOT分析
    PTT Exploration and Production Public Co Ltd (PTTEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Tactical Missiles Corporation:企業の戦略・SWOT・財務情報
    Tactical Missiles Corporation - Strategy, SWOT and Corporate Finance Report Summary Tactical Missiles Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • PT Bank Central Asia Tbk:企業の戦略・SWOT・財務情報
    PT Bank Central Asia Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Bank Central Asia Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Proton Holdings Berhad:企業の戦略的SWOT分析
    Proton Holdings Berhad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Iron Mountain Inc (IRM):企業の財務・戦略的SWOT分析
    Iron Mountain Inc (IRM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Gradalis Inc-製薬・医療分野:企業M&A・提携分析
    Summary Gradalis Inc (Gradalis), formerly Murex Pharmaceuticals, is a biopharmaceutical company which focuses on the development and commercialization of therapies for the treatment of cancer. Its developmental pipeline comprises of candidates for various cancer indications which include ovarian, br …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆